TRACK Study Update from The George Institute for Global Health

No images? Click here


Join us is an easy way for millions of Australians to participate in life-saving health and medical research.

Issue 18 � 31st Oct 2023

Study Overview

The TRACK trial will evaluate whether a small dose of rivaroxaban, a blood-thinning medication, would reduce cardiovascular death or major cardiovascular events in patients with advanced stages of chronic kidney disease.